Results showed that, compared to placebo, subjects taking the black seed and astaxanthin blend reported significantly fewer upper-respiratory tract complaints and better overall well-being, as well as lower cortisol and superior microbiome indices.
A recent study1 investigated the effects of a proprietary black seed oil, ThymoQuin, when combined with AstaPure astaxanthin in endurance runners. In the study, 32 subjects (21 male and 11 female) runners were given either a placebo of a soft-gel oil blend containing 500 mg of the black see oil with 8 mg of the astaxanthin oleoresin for four weeks. Supplementation took place three weeks prior to and one week following a marathon or half-marathon competition. Researchers collected profile of mood state (POMS) psychological assessments and health log questionnaires from subjects assessing health status and upper-respiratory tract complaints (URTCs), as well as provided saliva samples and fecal samples for measurement of cortisol and microbiome balance.
Results showed that, compared to placebo, subjects taking the black seed and astaxanthin blend reported significantly fewer URTCs and better overall well-being, as well as lower cortisol and superior microbiome indices. These results suggest that the combination of black seed oil and astaxanthin supports immune health and overall well-being following endurance training and competition by way of the microbiome.
“These results demonstrate a significant and meaningful benefit to balance the overall immune system and to aid in a better mood state,” said Morris Zelkha, CEO of TriNutra, the manufacturer of ThymoQuin, in a press release. “When the entire system is balanced, as evidenced here in the Supplement group, there is a noticeable benefit for physical health and mental wellness. This study continues to add to the arsenal of published studies demonstrating ThymoQuin’s potent and powerful effects as a stand-alone ingredient and a powerful and synergistic ingredient.”
Reference
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.